Minireviews
Copyright ©The Author(s) 2021.
World J Clin Cases. Jun 16, 2021; 9(17): 4133-4142
Published online Jun 16, 2021. doi: 10.12998/wjcc.v9.i17.4133
Figure 1
Figure 1 Interwoven relationships between nonalcoholic fatty liver disease, coronavirus disease 2019, interleukin-6, risk factors for coronavirus disease 2019, and effect of lockdown. The risk factors for coronavirus disease 2019 (COVID-19) are infection, lung injury, liver fibrosis, and cardiac impairment. IL-6: Interleukin–6; NAFLD: Nonalcoholic fatty liver disease.